Flagship’s Afeyan Sees UK Bet Creating Next Moderna
Flagship Pioneering is expanding its operations beyond the United States with the launch of its first full-scale biotech company-creation hub in the United Kingdom. CEO Noubar Afeyan expects this investment to grow to 600 million pounds as the firm aims to replicate its domestic model of establishing and scaling new life sciences ventures.
Covered by 1 source
- BBloomberg Technology↗6d ago